SS Innovations International, Inc.SSII
Price (close)
$2.95
Market cap
$590.5M
P/E
—
Revenue (TTM)
$52.4M
Net income
-$12.4M
Dividend yield
—
1-year total return
-47.8%
Net margin
-23.7%
Revenue growth
89.7%
Debt / equity
—
What SS Innovations International, Inc. does.
focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. We design, manufacture and
market an advanced, next-generation and affordable surgical robotic system called the SSi Mantra Surgical Robotic System (the “ SSi
Mantra ”) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic and cardiac
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | $1.4M | $5.9M | $20.6M | $42.5M |
| Net income | -$1.1M | -$1.5M | -$3.2M | -$20.9M | -$19.2M | -$12.1M |
| Free cash flow | — | — | -$6.2M | -$15.8M | -$10.2M | -$22.2M |
More on SSII.
- SS Innovations International, Inc. summary
- SS Innovations International, Inc. financial statements
- SS Innovations International, Inc. key metrics
- SS Innovations International, Inc. health scores and style box
- SS Innovations International, Inc. earnings
- SS Innovations International, Inc. dividends
- SS Innovations International, Inc. valuation
- SS Innovations International, Inc. ownership and insiders
- SS Innovations International, Inc. peers
Figures from SS Innovations International, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.